Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

HitGen, Almirall ink discovery deal
May 2019
SHARING OPTIONS:

CHENGDU, China—HitGen Ltd and Almirall shared news recently that they had teamed up in a research collaboration for the identification of novel small-molecule leads. While specific targets and financial details were not released, the collaboration will consist of HitGen leveraging its technology platform to discover novel leads for Almirall. In return, HitGen will receive upfront payments and is eligible to receive milestone payments as well.
 
“We are delighted to enter this collaboration with Almirall, a leading medical dermatology focused global pharmaceutical company. This collaboration further emphasizes the role of HitGen in the rapidly developing field of DNA-encoded chemistry. We will work closely with Almirall scientists to generate novel leads for their innovative research programs to address unmet medical needs,” said Dr. Jin Li, chairman and CEO of HitGen.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.